ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 38378317

Fusion genes in pancreatic tumors.

Gkountakos A and 4 others. Trends Cancer, 2024. Cited by 30 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Fusion genes in pancreatic tumors. Papers, record 38378317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38378317

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fusion genes in pancreatic tumors.
PubMed
Journal
Trends Cancer
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
3.57, provisional
iCite
Revised in PubMed
2026-08-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gkountakos AAnastasios
2Singhi ADAatur D
3Westphalen CBC Benedikt
4Scarpa AAldo
5Luchini CClaudio

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
Oncogene Proteins, FusionMajor topic
Humans
Biomarkers, Tumor
Receptor, trkA
Proto-Oncogene Proteins c-ret
Proto-Oncogene Proteins B-raf
Receptor, Fibroblast Growth Factor, Type 2
Neuregulin-1
Anaplastic Lymphoma Kinase
Gene Fusion

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R37 CA263622NCI NIH HHSUnited StatesR37CA263622PubMed

Source NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References81

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119,622,552The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.BMJ2009https://conductscience.org/library/papers/19622552PubMed
233,406,492Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.J Natl Compr Canc Netw2021https://conductscience.org/library/papers/33406492PubMed
336,240,849Exceptional Response to Erdafitinib in FGFR2-Mutated Metastatic Pancreatic Ductal Adenocarcinoma.J Natl Compr Canc Netw2022https://conductscience.org/library/papers/36240849PubMed
436,999,792Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications.Cancer Med2023https://conductscience.org/library/papers/36999792PubMed
535,135,829Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.Cancer Discov2022https://conductscience.org/library/papers/35135829PubMed
625,266,736Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes.Cancer Discov2014https://conductscience.org/library/papers/25266736PubMed
735,949,061AGAP3: A novel BRAF fusion partner in pediatric pancreatic-type acinar cell carcinoma.Genes Chromosomes Cancer2022https://conductscience.org/library/papers/35949061PubMed
837,313,463Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing.Front Oncol2023https://conductscience.org/library/papers/37313463PubMed
937,139,148RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report.Front Oncol2023https://conductscience.org/library/papers/37139148PubMed
1028,199,314Whole-genome landscape of pancreatic neuroendocrine tumours.Nature2017https://conductscience.org/library/papers/28199314PubMed

1 to 10 of 81

See all 81 references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42,512,378Pancreatic Acinar Cell Carcinoma: A Rare Pancreatic Malignancy with Distinct Biology and Emerging Therapeutic Opportunities.Cancers (Basel)2026https://conductscience.org/library/papers/42512378PubMed
42,474,629Precision Medicine in Pancreatic Cancer: Targeting KRAS and Beyond.Target Oncol2026https://conductscience.org/library/papers/42474629PubMed
42,402,589In situ imaging of proximal biomolecules via Proximity Anchored Modules Assembly.J Nanobiotechnology2026https://conductscience.org/library/papers/42402589PubMed
42,243,580EWSR1::BEND2 gene fusions characterize a majority of ACTH-producing neuroendocrine neoplasms of the pancreas: A follow-up study and brief review of the recent literature.Virchows Arch2026https://conductscience.org/library/papers/42243580PubMed
42,149,255Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer.Discov Oncol2026https://conductscience.org/library/papers/42149255PubMed
41,646,273Early-onset enriches the identification of actionable alterations in patients with KRAS wild-type pancreatic ductal adenocarcinoma.ESMO Gastrointest Oncol2025https://conductscience.org/library/papers/41646273PubMed
41,639,431DNA sandwich nanozyme-based colorimetric and photothermal biosensor for high-efficiency detection of fusion genes.Anal Bioanal Chem2026https://conductscience.org/library/papers/41639431PubMed
41,390,931NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer.J Natl Cancer Inst2026https://conductscience.org/library/papers/41390931PubMed
41,374,970KRAS-Wild Pancreatic Cancer-More Targets than Treatment Possibilities?Cancers (Basel)2025https://conductscience.org/library/papers/41374970PubMed
41,060,713Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures.United European Gastroenterol J2025https://conductscience.org/library/papers/41060713PubMed

1 to 10 of 20

See all 20 cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
FGFR22,263PubTator's text mininghttps://conductscience.org/library/genes/2263NCBI Gene
KRAS3,845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
NRG13,084PubTator's text mininghttps://conductscience.org/library/genes/3084NCBI Gene
RET5,979PubTator's text mininghttps://conductscience.org/library/genes/5979NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38378317

GET https://conductscience.org/api/papers/v1/38378317/references?page=2

API referenceFor AI assistants